Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 26% ± 8% | |
| glutamatergic neuron | 5 studies | 50% ± 24% | |
| GABAergic neuron | 5 studies | 45% ± 18% | |
| oligodendrocyte | 5 studies | 26% ± 6% | |
| interneuron | 5 studies | 39% ± 25% | |
| epithelial cell | 4 studies | 21% ± 3% | |
| retina horizontal cell | 4 studies | 19% ± 3% | |
| astrocyte | 4 studies | 30% ± 8% | |
| oligodendrocyte precursor cell | 3 studies | 30% ± 7% | |
| fibroblast | 3 studies | 22% ± 6% | |
| adipocyte | 3 studies | 20% ± 3% | |
| neuron | 3 studies | 30% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 37% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 5809.96 | 2641 / 2642 | 100% | 22.25 | 704 / 705 |
| breast | 100% | 4054.16 | 459 / 459 | 99% | 27.11 | 1109 / 1118 |
| prostate | 100% | 3611.38 | 245 / 245 | 99% | 15.05 | 497 / 502 |
| lung | 99% | 2762.44 | 575 / 578 | 99% | 16.45 | 1149 / 1155 |
| kidney | 100% | 2418.79 | 89 / 89 | 99% | 15.99 | 891 / 901 |
| thymus | 100% | 3228.86 | 653 / 653 | 99% | 13.19 | 598 / 605 |
| esophagus | 100% | 3163.02 | 1442 / 1445 | 99% | 13.42 | 181 / 183 |
| uterus | 100% | 3893.06 | 170 / 170 | 97% | 11.34 | 446 / 459 |
| pancreas | 99% | 2034.34 | 326 / 328 | 98% | 12.49 | 174 / 178 |
| adrenal gland | 100% | 2652.00 | 257 / 258 | 97% | 14.66 | 223 / 230 |
| intestine | 100% | 3493.63 | 965 / 966 | 96% | 9.15 | 508 / 527 |
| ovary | 100% | 4605.97 | 180 / 180 | 96% | 9.66 | 414 / 430 |
| bladder | 100% | 3375.95 | 21 / 21 | 96% | 11.49 | 482 / 504 |
| stomach | 99% | 2365.78 | 357 / 359 | 96% | 10.00 | 275 / 286 |
| skin | 100% | 2714.02 | 1806 / 1809 | 95% | 13.68 | 450 / 472 |
| liver | 77% | 748.15 | 175 / 226 | 52% | 3.40 | 210 / 406 |
| adipose | 100% | 4347.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3927.19 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2723.83 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 11.50 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.75 | 1 / 1 |
| muscle | 99% | 1706.80 | 795 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 2270.51 | 830 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 11.27 | 75 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 8.24 | 26 / 29 |
| peripheral blood | 38% | 1097.30 | 349 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0019433 | Biological process | triglyceride catabolic process |
| GO_0000266 | Biological process | mitochondrial fission |
| GO_0090141 | Biological process | positive regulation of mitochondrial fission |
| GO_0034389 | Biological process | lipid droplet organization |
| GO_0007626 | Biological process | locomotory behavior |
| GO_0008542 | Biological process | visual learning |
| GO_0005829 | Cellular component | cytosol |
| GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0034451 | Cellular component | centriolar satellite |
| GO_0016020 | Cellular component | membrane |
| GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
| GO_0004806 | Molecular function | triglyceride lipase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | DDHD2 |
| Protein name | Phospholipase DDHD2 (EC 3.1.1.-) (DDHD domain-containing protein 2) (KIAA0725p) (SAM, WWE and DDHD domain-containing protein 1) DDHD domain containing 2 |
| Synonyms | SAMWD1 KIAA0725 |
| Description | FUNCTION: Phospholipase that hydrolyzes preferentially phosphatidic acid, including 1,2-dioleoyl-sn-phosphatidic acid, and phosphatidylethanolamine. Specifically binds to phosphatidylinositol 3-phosphate (PI(3)P), phosphatidylinositol 4-phosphate (PI(4)P), phosphatidylinositol 5-phosphate (PI(5)P) and possibly phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). May be involved in the maintenance of the endoplasmic reticulum and/or Golgi structures. May regulate the transport between Golgi apparatus and plasma membrane. . |
| Accessions | ENST00000533100.5 E9PM60 E9PKE6 O94830 ENST00000526237.5 ENST00000528358.5 ENST00000532222.5 E9PQY9 ENST00000528613.1 E9PP45 E9PPN2 H0YE64 ENST00000532106.1 ENST00000397166.7 [O94830-1] ENST00000527834.5 ENST00000527415.5 ENST00000517385.5 [O94830-2] ENST00000520272.6 [O94830-1] E9PPH8 H0YF17 ENST00000526144.1 E9PIF5 ENST00000529845.5 H0YF30 E9PK57 ENST00000529642.1 |